Subscribe to RSS
DOI: 10.1055/s-0040-1710837
Emergency treatment of anaphylaxis
Anaphylaxis is an acute allergic reaction with potentially systemic symptoms that can lead to life-threatening conditions. There is no global norm for the definition or classification of anaphylaxis. Likewise, there is no consistent recommendation for therapy because of different existing guidelines around the world. Fast and proper emergency treatment can prevent death. Adrenaline is the most important drug in the emergency treatment of anaphylaxis. The AMWF guideline recommends the use of adrenaline intramuscular from grade II anaphylactic reactions (classification modified according to Ring and Messmer).
This study shows data from emergency physicians of the air rescue Dresden, Germany. Data from 152 adults and 29 children was evaluated. The data includes demographic data, triggers and symptoms of anaphylactic reactions as well as acute treatment. The data shows that 21 % of adults with grade II-IV anaphylactic reactions received adrenaline. Regarding children, it was only administered in 7 % of the cases of grade II-IV anaphylactic reactions. As currently discussed, the treatment with adrenaline should become the focus of attention and enter the routine use of emergency therapy of anaphylactic reactions. A consistent and possibly global guideline would be useful for the treatment of anaphylaxis.
Poster-PDF A-1531.PDF
Publication History
Article published online:
10 June 2020
© 2020. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).
© Georg Thieme Verlag KG
Stuttgart · New York